132 related articles for article (PubMed ID: 34638419)
1. PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells.
Haque MA; Abdelaziz M; Puteri MU; Vo Nguyen TT; Kudo K; Watanabe Y; Kato M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638419
[TBL] [Abstract][Full Text] [Related]
2. PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells.
Puteri MU; Watanabe Y; Wardhani BWK; Amalia R; Abdelaziz M; Kato M
Genes Cells; 2020 Jun; 25(6):375-390. PubMed ID: 32181976
[TBL] [Abstract][Full Text] [Related]
3. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
[TBL] [Abstract][Full Text] [Related]
4. TMEPAI promotes degradation of the NF-κB signaling pathway inhibitory protein IκBα and contributes to tumorigenesis.
Li Y; Zhang Y; Li L; Zhang M; Song N; Zhao Q; Liu Z; Diao A
Int J Biol Macromol; 2023 Apr; 235():123859. PubMed ID: 36868334
[TBL] [Abstract][Full Text] [Related]
5. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Saikumar P
Genes Cancer; 2014 Sep; 5(9-10):320-36. PubMed ID: 25352949
[TBL] [Abstract][Full Text] [Related]
6. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells.
Vo Nguyen TT; Watanabe Y; Shiba A; Noguchi M; Itoh S; Kato M
Cancer Sci; 2014 Mar; 105(3):334-41. PubMed ID: 24438557
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
Wardhani BW; Puteri MU; Watanabe Y; Louisa M; Setiabudy R; Kato M
J Exp Pharmacol; 2020; 12():17-26. PubMed ID: 32158279
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration.
Wardhani BWK; Louisa M; Watanabe Y; Setiabudy R; Kato M
Breast Cancer (Dove Med Press); 2021; 13():529-538. PubMed ID: 34584450
[TBL] [Abstract][Full Text] [Related]
9. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
10. Cooperative induction of transmembrane prostate androgen induced protein TMEPAI/PMEPA1 by transforming growth factor-β and epidermal growth factor signaling.
Azami S; Vo Nguyen TT; Watanabe Y; Kato M
Biochem Biophys Res Commun; 2015 Jan; 456(2):580-5. PubMed ID: 25482449
[TBL] [Abstract][Full Text] [Related]
11. TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.
Amalia R; Abdelaziz M; Puteri MU; Hwang J; Anwar F; Watanabe Y; Kato M
Cell Signal; 2019 Jul; 59():24-33. PubMed ID: 30890370
[TBL] [Abstract][Full Text] [Related]
12. SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells.
Gao G; Kun T; Sheng Y; Qian M; Kong F; Liu X; Yu Z; Zhang H; Zhang Q; Gu J; Zhang X
Mol Biol Rep; 2013 Apr; 40(4):2947-53. PubMed ID: 23440515
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.
Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS
J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347
[TBL] [Abstract][Full Text] [Related]
14. Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Dobi A; Srivastava S; Saikumar P
Genes Cancer; 2019; 10(5-6):134-149. PubMed ID: 31798766
[TBL] [Abstract][Full Text] [Related]
15. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
16. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
[TBL] [Abstract][Full Text] [Related]
17. PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.
Abdelaziz M; Watanabe Y; Kato M
J Biochem; 2019 May; 165(5):411-414. PubMed ID: 30873542
[TBL] [Abstract][Full Text] [Related]
18. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
[TBL] [Abstract][Full Text] [Related]
19. Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.
Moc C; Taylor AE; Chesini GP; Zambrano CM; Barlow MS; Zhang X; Gustafsson ÅB; Purcell NH
Cardiovasc Res; 2015 Feb; 105(2):160-70. PubMed ID: 25411382
[TBL] [Abstract][Full Text] [Related]
20.
Sharad S; Dobi A; Srivastava S; Srinivasan A; Li H
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32842649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
